Comparative Study of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After Transurethral Resection of the Prostate
Condition: Overactive Bladder Syndrome Interventions: Drug: Solifenacin 5Mg; Drug: Mirabegron 50 MG Sponsor: Buddhist Tzu Chi General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2018 Category: Research Source Type: clinical trials
